Drug Report History #141744
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v6-FR | Version v1-EN | |
|---|---|---|
| Language (Changed) | Updated to: French | Was: English |
| Date Updated (Changed) | Updated to: 2022-01-08 | Was: 2021-07-02 |
| Drug Identification Number | 02479109 | 02479109 |
| Brand name | SODIUM NITROPRUSSIDE FOR INJECTION | SODIUM NITROPRUSSIDE FOR INJECTION |
| Common or Proper name | Sodium Nitroprusside | Sodium Nitroprusside |
| Company Name | MARCAN PHARMACEUTICALS INC | MARCAN PHARMACEUTICALS INC |
| Ingredients | SODIUM NITROPRUSSIDE | SODIUM NITROPRUSSIDE |
| Strength(s) | 25MG | 25MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 Vial | 1 Vial |
| Additional packaging sizes | ||
| ATC code | C02DD | C02DD |
| ATC description | ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON | ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-06-20 | 2021-06-20 |
| Actual start date | 2021-06-20 | 2021-06-20 |
| Estimated end date (Changed) | Updated to: 2022-01-31 | Was: 2021-11-30 |
| Actual end date (Changed) | Updated to: 2022-01-07 | Was: |
| Shortage status (Changed) | Updated to: Resolved | Was: Actual shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |